中国中药(00570.HK) 公布,国药集团共裕按每股4.6元将公司私有化建议之先决条件仍未得到满足。因此,建议于10月18日失效,股份在联交所的上市地位将不会撤销。
中国中药今早(21日)低开14.92%报3.25元后初段跌幅急扩,最低见2.12元。现报2.25元,跌41.1%,成交1.82亿股,涉资4.18亿元,市值降至约115亿元。(ad/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-18 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.